Haemophilia is a rare inherited blood disorder characterised by poor blood clotting. It is typically caused by inherited gene changes affecting the production of clotting factors.
The severity of Hemophilia is classified into three categories: mild, moderate, or severe. In severe cases, internal bleeding, such as bleeding in the brain, can occur and poses a serious risk.
Diagnosis is confirmed through blood tests that measure the levels of clotting factors. While there is no cure, significant advancements in treatment allow many individuals to live near-normal life expectancies.
Treatment primarily involves clotting factor replacement therapy, supplemented by newer, innovative therapies to manage and prevent bleeding episodes.
